<DOC>
	<DOCNO>NCT01024101</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety paclitaxel give weekly patient advance recurrent head neck cancer</brief_summary>
	<brief_title>Early Phase II Study Weekly Paclitaxel ( BMS-181339 ) Patient With Advanced Recurrent Head Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Patients locally advanced head neck cancer pretreated surgery and/or radiotherapy suitable radical local treatment patient distant metastasis may receive one chemotherapy regimen Patients serious , uncontrolled medical illness</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>